Young-Soo Kim

Young-Soo Kim

Auto-generated profile, based on publicly available information

Young-Soo Kim

Department of Food Science and Technology, Jeonbuk National University, Jeonju 54896, Republic of Korea

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2022 in Carbohydrate Polymers
Verified
Journal Article
Closed access
HLHye-Bin Lee
Hye-Bin Lee
YKYoung-Soo Kim
Young-Soo Kim
HPHo-Young Park
Ho-Young Park

18 June 2012 in Journal of Food Science
Verified
Journal Article
Closed access
PDF file
HJHyun‐Il Jun
Hyun‐Il Jun
GSGeun‐Seoup Song
Geun‐Seoup Song
EYEun‐In Yang
Eun‐In Yang
YYYoung Youn
Young Youn
YKYoung‐Soo Kim
Young‐Soo Kim

30 April 2013 in Food Science and Biotechnology
Verified
Journal Article
Closed access
PDF file
MCMi-Na Cha
Mi-Na Cha
HJHyun-Il Jun
Hyun-Il Jun
WLWon-Jae Lee
Won-Jae Lee
MKMin-Ji Kim
Min-Ji Kim
MKMyung-Kon Kim
Myung-Kon Kim
YKYoung-Soo Kim
Young-Soo Kim

13 December 2024 in Metabolites
Verified
Journal Article
Open access
PDF file
JPJi-Eun Park
Ji-Eun Park
HPHo-Young Park
Ho-Young Park
YKYoung-Soo Kim
Young-Soo Kim
MPMiri Park
Miri Park
Background/Objectives: Dietary patterns, including high-fat and high-carbohydrate diets (HFDs and HCDs), as well as non-dietary factors such as food additives and antibiotics, are strongly linked to metabolic endotoxemia, a critical driver of low-grade chronic inflammation. This review explores the mechanisms through which these factors impair intestinal permeability, disrupt gut microbial balance, and facilitate lipopolysaccharide (LPS) translocation into the bloodstream, contributing to metabolic disorders such as obesity, type 2 diabetes mellitus, and inflammatory bowel disease. Methods: The analysis integrates findings from recent studies on the effects of dietary components and gut microbiota interactions on intestinal barrier function and systemic inflammation. Focus is given to experimental designs assessing gut permeability using biochemical and histological methods, alongside microbiota profiling in both human and animal models. Results: HFDs and HCDs were shown to increase intestinal permeability and systemic LPS levels, inducing gut dysbiosis and compromising barrier integrity. The resulting endotoxemia promoted a state of chronic inflammation, disrupting metabolic regulation and contributing to the pathogenesis of various metabolic diseases. Food additives and antibiotics further exacerbated these effects by altering microbial composition and increasing gut permeability. Conclusions: Diet-induced alterations in gut microbiota and barrier dysfunction emerge as key mediators of metabolic endotoxemia and related disorders. Addressing dietary patterns and their impact on gut health is crucial for developing targeted interventions. Further research is warranted to standardize methodologies and elucidate mechanisms for translating these findings into clinical applications.

2 April 2019 in Molecules
Verified
Journal Article
Open access
PDF file
Denis Nchang CheDenis Nchang Che
Denis Nchang Che
BCByoung Ok Cho
Byoung Ok Cho
JSJae Young Shin
Jae Young Shin
HKHyun Ju Kang
Hyun Ju Kang
JKJi-Su Kim
Ji-Su Kim
SJSeon Il Jang
Seon Il Jang
IL-31 is a recently discovered cytokine that is produced not only in T-cells but also in mast cells. It is strongly implicated to play a key role in inflammatory diseases and in the pathogenesis of itch in atopic dermatitis. Apigenin, a flavonoid of plant origin has numerous biological applications. In this study, we showed that apigenin modulates IL-31 mRNA, protein expression, and release in stimulated human mast (HMC-1) by inhibiting the phosphorylation activation of MAPK and NF-κB. To determine whether apigenin has similar effects in vivo, using Compound 48/80, we developed an atopic dermatitis itch model in mice and found an increase in IL-31 expression in the skin. We also revealed that apigenin prevents the infiltration and degranulation of mast cells and suppressed mRNA and protein expression of IL-31 in the skin of mice. These results provide a new suggestion of the potential applicability of apigenin for treatment of various inflammatory diseases and itch mediated by IL-31.

11 June 2019 in Foods
Verified
Journal Article
Open access
YGYoseph Asmelash Gebru
Yoseph Asmelash Gebru
JHJun Hyun-Ii
Jun Hyun-Ii
KYKim Young-Soo
Kim Young-Soo
MKMyung-Kon Kim
Myung-Kon Kim
KKKwang-Pyo Kim
Kwang-Pyo Kim
Data on variations in amino acid compositions and protein profiles among white and brown teff, a grain of growing interest, is either limited or contradicting at the moment. In this study, three white (Addis-W, Mekel-W and Debre-W) and three brown (Addis-B, Mekel-B and Debre-B) teff seed samples were used for whole flour amino acid analysis and protein fractionation with three different methods. White and brown seed types showed different physical changes during protein extraction. Brown teff displayed higher essential amino acid content than white with lysine present in high concentration in both seed types. Extraction with tert-butanol increased prolamin yields in teff compared to ethanol. The major protein fraction in teff was glutelin with white teff containing higher glutelin proportion than brown. Sodium Dodecyl Sulfate Gel Electrophoresis (SDS-PAGE) analysis revealed clear genetic variability between white and brown teff seed types.